Personalized regression enables sample-specific pan-cancer analysis

被引:9
|
作者
Lengerich, Benjamin J. [1 ]
Aragam, Bryon [2 ]
Xing, Eric P. [1 ,2 ,3 ]
机构
[1] Carnegie Mellon Univ, Dept Comp Sci, Pittsburgh, PA 15213 USA
[2] Carnegie Mellon Univ, Machine Learning Dept, Pittsburgh, PA 15213 USA
[3] Petuum Inc, Pittsburgh, PA 15222 USA
关键词
HETEROGENEITY; EXPRESSION; ONTOLOGY;
D O I
10.1093/bioinformatics/bty250
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Motivation: In many applications, inter-sample heterogeneity is crucial to understanding the complex biological processes under study. For example, in genomic analysis of cancers, each patient in a cohort may have a different driver mutation, making it difficult or impossible to identify causal mutations from an averaged view of the entire cohort. Unfortunately, many traditional methods for genomic analysis seek to estimate a single model which is shared by all samples in a population, ignoring this inter-sample heterogeneity entirely. In order to better understand patient heterogeneity, it is necessary to develop practical, personalized statistical models. Results: To uncover this inter-sample heterogeneity, we propose a novel regularizer for achieving patient-specific personalized estimation. This regularizer operates by learning two latent distance metrics-one between personalized parameters and one between clinical covariates- and attempting to match the induced distances as closely as possible. Crucially, we do not assume these distance metrics are already known. Instead, we allow the data to dictate the structure of these latent distance metrics. Finally, we apply our method to learn patient-specific, interpretable models for a pan-cancer gene expression dataset containing samples from more than 30 distinct cancer types and find strong evidence of personalization effects between cancer types as well as between individuals. Our analysis uncovers sample-specific aberrations that are overlooked by population-level methods, suggesting a promising new path for precision analysis of complex diseases such as cancer.
引用
收藏
页码:178 / 186
页数:9
相关论文
共 50 条
  • [41] Pan-cancer analysis of the deoxyribonuclease gene family
    Bai, Qingquan
    He, Xiao
    Hu, Tianhui
    MOLECULAR AND CLINICAL ONCOLOGY, 2023, 18 (03)
  • [42] Pan-cancer analysis for oncogenes and mechanisms of their upregulation
    Dmitriev, A. A.
    Krasnov, G. S.
    Melnikova, N. V.
    Pushkova, E. N.
    Novakovskiy, R. O.
    Kudryavtseva, A. V.
    Beniaminov, A. D.
    ANNALS OF ONCOLOGY, 2019, 30
  • [43] A COMPREHENSIVE PAN-CANCER ANALYSIS OF CHILDHOOD MALIGNANCIES
    Groebner, Susanne N.
    Worst, Barbara
    Jones, David T. W.
    Buchhalter, Ivo
    Kleinheinz, Kortine
    Weischenfeldt, Joachim
    Johann, Pascal D.
    Segura-Wang, Maia
    Northcott, Paul A.
    Kool, Marcel
    Hutter, Barbara
    Bender, Sebastian
    Korbel, Jan O.
    Schlesner, Matthias
    Chavez, Lukas
    Zapatka, Marc
    Lichter, Peter
    Pfister, Stefan M.
    NEURO-ONCOLOGY, 2016, 18 : 171 - 172
  • [44] Proteogenomic data and resources for pan-cancer analysis
    Li, Yize
    Dou, Yongchao
    Leprevost, Felipe Da Veiga
    Geffen, Yifat
    Calinawan, Anna P.
    Akiyama, Yo
    Anand, Shankara
    Birger, Chet
    Cao, Song
    Chaudhary, Rekha
    Chilappagari, Padmini
    Cieslik, Marcin
    Colaprico, Antonio
    Zhou, Daniel Cui
    Day, Corbin
    Domagalski, Marcin J.
    Aguet, Francois
    Fenyo, David
    Selvan, Myvizhi Esai
    Foltz, Steven M.
    Francis, Alicia
    Gonzalez-Robles, Tania
    Euromueuros, Zeynep H.
    Heiman, David
    Holck, Michael
    Hong, Runyu
    Hu, Yingwei
    Jaehnig, Eric J.
    Ji, Jiayi
    Jiang, Wen
    Katsnelson, Lizabeth
    Ketchum, Karen A.
    Klein, Robert J.
    Lei, Jonathan T.
    Liang, Wen-Wei
    Liao, Yuxing
    Lindgren, Caleb M.
    Ma, Weiping
    Ma, Lei
    Maccoss, Michael J.
    Rodrigues, Fernanda Martins
    Mckerrow, Wilson
    Nguyen, Ngoc
    Oldroyd, Robert
    Pilozzi, Alexander
    Pugliese, Pietro
    Reva, Boris
    Rudnick, Paul
    Ruggles, Kelly V.
    Rykunov, Dmitry
    CANCER CELL, 2023, 41 (08) : 1397 - 1406
  • [45] Integrative analysis the characterization of peroxiredoxins in pan-cancer
    Lei Gao
    Jialin Meng
    Chuang Yue
    Xingyu Wu
    Quanxin Su
    Hao Wu
    Ze Zhang
    Qinzhou Yu
    Shenglin Gao
    Song Fan
    Li Zuo
    Cancer Cell International, 21
  • [46] Pan-cancer stemness defined by CPTAC proteogenomics guides personalized therapies.
    Wiznerowicz, Maciej
    Colaprico, Antono
    Storrs, Erik
    Petralia, Francesca
    Kolodziejczak, Iga
    Leprevost, Felipe Da Veiga
    Ma, Weiping
    Zhou, Daniel Cui
    Wen, Bo
    Lazar, Alexander
    Pugliese, Pietro
    Ceccarelli, Michele
    Kaminska, Bozena
    Lubinski, Jan
    Nesvizhskii, Alexey
    Zhang, Bing
    Rodriguez, Henry
    Robles, Ana L.
    Mesri, Mehdi
    CANCER RESEARCH, 2021, 81 (13)
  • [47] Systematic pan-cancer analysis of tumour purity
    Aran, Dvir
    Sirota, Marina
    Butte, Atul J.
    NATURE COMMUNICATIONS, 2015, 6
  • [48] Pan-cancer analysis of BRAF alterations and tumor-specific mechanisms of activation.
    Bergom, Hannah E.
    Toye, Eamon P.
    Shi, Xiaolei
    Ryan, Charles J.
    Antonarakis, Emmanuel S.
    Hwang, Justin
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E17005 - E17005
  • [49] Sample-specific linearization in reliability analysis of off-shore structures
    Dept. of Civ. Eng. and Surveying, University of Newcastle, Newcastle, NSW, Australia
    Struct Saf, 2-3 (101-122):
  • [50] Sample-specific perturbation of gene interactions identifies breast cancer subtypes
    Chen, Yuanyuan
    Gu, Yu
    Hu, Zixi
    Sun, Xiao
    BRIEFINGS IN BIOINFORMATICS, 2021, 22 (04)